Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teneo Restructuring is the specialized financial advisory and insolvency division of Teneo, a global CEO advisory firm. While not a biotechnology developer, the firm is a prominent service provider in the life sciences and healthcare sectors, offering expertise in turnaround management, debt advisory, and formal insolvency proceedings for distressed organizations. The division gained significant global scale through the 2021 acquisition of Deloitte's UK restructuring business, positioning it as a lead advisor for complex cross-border financial reorganizations. Teneo Restructuring frequently manages high-profile cases in the healthcare space, assisting creditors and boards in preserving value during periods of financial instability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Teneo Restructuring.